Mutations in RPE65 or lecithin-retinol acyltransferase (LRAT) disrupt 11-cis-retinal synthesis and cause Leber congenital amaurosis (LCA). In Lrat -/mouse model, mislocalized medium (M)-wavelength sensitive opsin was degraded whereas mislocalized short (S)-wavelength sensitive opsin accumulated before the onset of cone degeneration. The mechanism for the foveal medium (M)/long (L)-wavelength-sensitive cone degeneration in LCA is unknown. By crossing Lrat -/mice with a proteasome reporter mouse line, we showed that M-opsin enriched dorsal cones in Lrat -/mice exhibit proteasome stress due to the degradation of large amounts of Mopsin. Deletion of M-opsin relieves the proteasome stress and completely prevents "M cone" degeneration in Lrat -/-Opn1sw -/mice (a pure "M cone" LCA model, Opn1sw -/encoding Sopsin) for at least 12 months. Our results suggest that M-opsin degradation associated proteasome stress plays a major role in "M cone" degeneration in Lrat -/model. This finding may represent a general mechanism for "M cone" degeneration for multiple forms of cone degeneration due to M-opsin mislocalization and degradation. Our results have important implications for the current gene therapy strategy for LCA that emphasizes the need for a combinatorial therapy to both improve vision and slow photoreceptor degeneration.
Introduction
Retinoid isomerase (RPE65) and lecithin-retinol acyltransferase (LRAT) are two key enzymes involved in the generation/recycling of 11-cis-retinal in the retinal pigment epithelium (RPE).
Mutations in either gene lead to Leber congenital amaurosis (LCA), a severe inherited retinal degenerative disease characterized by severe loss of vision in childhood with early degeneration of foveal cones followed by rods (1, 2) . Two mouse models Rpe65 -/-(LCA2) and Lrat -/-(LCA14) mice, which have shown very similar phenotypes, and a Rpe65 -/dog model have been widely used for mechanistic and therapeutic studies (3) (4) (5) (6) (7) (8) (9) (10) (11) . These studies paved the way for the first successfully treated inherited retinopathy using gene therapy (12) (13) (14) . However, follow-up studies found that photoreceptor degeneration continued even after the gene therapy intervention in LCA2 (11, (15) (16) (17) , suggesting a need to understand the mechanism of photoreceptor degeneration to design improved treatment strategies.
In both LCA patients and animal models, both rod and cone functions are severely compromised due to a combination of 11-cis-retinal deficiency and photoreceptor degeneration. Early loss of foveal cones was reported in RPE65-deficient patients (1, 2) . Despite extensive studies, the mechanisms underlying cone degeneration in LCA are still poorly understood. In mouse models, both medium-wavelength sensitive opsin (M-opsin) and short-wavelength sensitive opsin (Sopsin) fail to traffic from the cone inner segment to the outer segment and cone photoreceptors in the central/ventral retina degenerate rapidly (< 4 weeks) (5) (6) (7) 18) . Dorsal cones degenerate slowly (> 6 months). We have shown previously that S-opsin was aggregation-prone in cell culture, and accumulated in cones leading to proapoptotic endoplasmic reticulum (ER) stress and rapid S-opsin enriched central/ventral cone ("S-cone") degeneration in Lrat -/mice (8) . Deletion of S-opsin reduced ER stress and completely prevented the rapid S-cone degeneration in Lrat -/-S-opsin -/mice for at least 12 months (19) . However, the mechanism for M-opsin enriched dorsal cone ("M cone") degeneration is unclear. Understanding the mechanism for M/L (medium/long-wavelength) cone degeneration is important since the human fovea is dominated by both cone types, which are responsible for high-resolution daylight vision and color perception (20) .
Our previous work has shown that mistargeted M-opsin was largely degraded whereas S-opsin was resistant to degradation in Lrat -/mice (8) . M-opsin was shown to be degraded by the proteasome but not lysosome pathway in Rpe65 -/mice (21) . Degradation of large amounts of mistargeted M-opsin in cones will likely overload proteasome and cause proteasome stress.
Interference with the proteasome inhibits both cytosolic protein degradation and ER-associated degradation (ERAD), which can lead to cell death. Indeed, the degradation of rod transduction proteins was shown to cause proteasome overload, ER stress, and rod degeneration (22) (23) (24) .
Moreover, decreased proteasomal activity causes rod degeneration (25) , whereas increased proteasomal activity delays rod degeneration (26) . However, the role of proteasome stress in cone degeneration has not been studied. Due to mixed expression of M-and S-opsins in mouse cones and the rapid degeneration caused by S-opsin in Lrat -/mice, we used the Lrat -/-Opn1sw -/mice as a pure "M cone" LCA model to study the role of M-opsin and proteasome stress in cone degeneration. We showed that deletion of M-opsin relieves the proteasome stress and prevents "M cone" degeneration in Lrat -/-Opn1sw -/mice for at least 12 months.
Results and Discussion
Previous studies have shown that M-opsin was degraded in Lrat -/mice (8, 19) and that M-opsin degradation was mediated by the proteasome but not lysosome pathway (21) . We hypothesize that the degradation of large amounts of mislocalized M-opsin can overload the ubiquitinproteasome system and cause proteasome stress. To examine proteasomal insufficiency in Lrat -/cones, we crossed Lrat -/with a proteasome reporter mouse line Ub G76V -GFP to generate Lrat -/-Ub G76V -GFP mice. Accumulation of Ub G76V -GFP (a cytoplasmic substrate carrying a degradation signal) indicates proteasomal insufficiency (27) . The accumulation of Ub G76V -GFP was detected by immunohistochemistry with an anti-GFP antibody (28) . Cones from all regions of P18 Lrat -/-Ub G76V -GFP displayed robust reporter signal throughout cones, i.e., from outer segment to synaptic terminal in green [Cones were labeled with rhodamine-peanut agglutinin (PNA) in red] ( Fig. 1 ). No cone specific-GFP signal was detected in control Ub G76V -GFP. Proteasomal insufficiency in central/ventral cones was likely caused by aggregated S-opsin mediated proteasome inhibition (29) (30) (31) (32) . Proteasome insufficiency in dorsal cones was likely caused by M-opsin degradation induced proteasome overload.
To overcome the difficulties associated with the mixed expression of M and S-opsins in mouse cones and the rapid degeneration caused by S-opsin in Lrat -/mice, we generated the Lrat -/-Opn1sw -/mice as a pure "M cone" LCA model to study the role of M-opsin in cone degeneration. We first generated Opn1mw -/mice by CRISPR/Cas9. Opn1mw was disrupted by 1 nucleotide insertion in the second exon, which causes a frame shift and truncation at the 2nd exon ( Fig. 2A &B, Supplementary Fig. 1 ). Opn1mw -/mice (male Opn1mw Y/and female Opn1mw -/mice) have normal body size and fertility. Immunohistochemistry and western blot confirmed the absence of M-opsin in the retina of Opn1mw -/mice ( Fig. 2 C & D). The expression level of S-opsin was increased in Opn1mw -/mice ( Figure 2C ), which mirrors the result of M-opsin upregulation in S-opsin -/mice due to transcriptional compensation (33) . We
Dorsal cones of Lrat -/-Opn1sw -/mice are morphologically unhealthy at 6 months with swollen outer and inner segment (Fig. 3A , white arrowheads). This became much worse at 12 months.
Most remaining cones have lost their outer segment ( Fig. 3A , white arrows) with broken or fragmented structure ( Fig. 3A , red arrows). Compared with WT, Lrat -/-Opn1sw -/mice have lost 26% (p<0.01) and 49% (p<0.001) cones at 6 and 12 months, respectively ( Fig. 3B ). In contrast, 97% and 94% dorsal cones survived in Lrat -/-Opn1sw -/-Opn1mw -/mice at 6 and 12 months, respectively, which is not significantly different from control WT and Opn1sw -/-Opn1mw -/mice, suggesting that M-opsin plays a major role in dorsal cone degeneration in Lrat -/mice. We have shown previously that deletion of S-opsin prevents ventral and central cone degeneration in Lrat -/-Opn1sw -/mice up to 12 months. We confirmed this result in Fig. 2B . Previous work by others and us have shown cones can survive with little cone opsins (i.e. ventral cones in Opn1sw -/and Lrat -/-Opn1sw -/mice) (19, 33) , our new data provide conclusive evidence that cones can survive with no cone opsins (i.e., 6-and 12-month Opn1sw -/-Opn1mw -/cones), which is quite different from rods that degenerate rapidly without rhodopsin (34) .
We bred Lrat -/-Opn1sw -/-Opn1mw -/and Lrat -/-Opn1sw -/mice with Ub G76V -GFP to generate G76V -GFP and Lrat -/-Opn1sw -/-Ub G76V -GFP mice to assess the role of proteasome stress in "M-cone" degeneration. In P18 Lrat -/-Opn1sw -/mice, dorsal cones displayed strong GFP signal indicating proteasome inefficiency (Fig. 3C, white arrows) . In contrast, dorsal cones from P18 Lrat -/-Opn1sw -/-Opn1mw -/-Ub G76V -GFP mice exhibited markedly decreased GFP signal, suggesting M-opsin degradation plays a major role for proteasome stress in M cones. Interestingly, GFP signal in the ventral and central cones in Lrat -/-Opn1sw -/-Opn1mw -/-Ub G76V -GFP mice was also decreased compared with those of Lrat -/-Opn1sw -/mice ( Supplementary Fig. 2) . One explanation is that in the absence of S-opsin, Mopsin is increased due to transcriptional compensation and causes proteasome stress in central and ventral cones ( Fig. 2C) (33) . The residual GFP signal in Lrat -/-Opn1sw -/-Opn1mw -/-Ub G76V -GFP mice compared with WT mice is likely caused by proteasome stress associated with the degradation of other cone phototransduction proteins (see below).
Several membrane-associated proteins, e.g., M/S opsins, G protein-coupled receptor kinase 1 (GRK1), cone transducin alpha subunit (Gαt2), involved in cone phototransduction fail to traffic to the outer segment of Lrat -/or Rpe65 -/cones properly (7) . The mistrafficked proteins are degraded through a posttranslational mechanism (7) , except that S-opsin aggregates and resists proteasome degradation (8) . We examined the subcellular localization of GRK1 and Gαt2 in the
GRK1 was expressed in both rods and cones ( Supplementary Fig. 3 , top left panel, white arrows indicating cone signal) in WT. In sharp contrast, no GRK1 signal was detected in cones in Lrat -/-Opn1sw -/-Opn1mw -/-, Opn1sw -/-Opn1mw -/-, and Lrat -/-Opn1sw -/mice ( Supplementary Fig.   3 , top right three panels). Gt2 was markedly reduced in Lrat -/-Opn1sw -/mice ( Supplementary   Fig. 3, 2nd bottom left panel) as we have shown previously (8) , and was undetectable in Lrat -/-Opn1sw -/-Opn1mw -/and Opn1sw -/-Opn1mw -/mice ( Supplementary Fig. 3 , bottom right two panels) compared to the robust signal in WT cones ( Supplementary Fig. 3 , bottom left panel, red arrows). These results suggest that the degradation of many cone membrane-associated proteins other than M-opsin does not play a significant role in cone viability likely due to their much smaller quantities than M-opsin although it may still cause some degree of proteasome stress (see Supplementary Fig. 1 ).
The major finding of this study is that deletion of M-opsin relieved proteasome stress and prevented the dorsal "M cone" degeneration in Lrat -/-S-opsin -/mice for at least one year. In the absence of 11-cis-retinal, daily degradation of large amounts of M-opsin could overload the proteasome and cause chronic proteasomal insufficiency, which may lead to the accumulation of misfolded proteins in the ER by inhibiting ERAD and triggering chronic ER stress in M cones.
On the other hand, chronic proteasomal insufficiency may also affect normal cellular function (35, 36) . Indeed, proteasome overload or impairment has been implicated in several types of rod degeneration associated with protein misfolding or mistargeting (23, (37) (38) (39) . To our knowledge, this is the first study to examine the role of proteasome stress in cone degeneration. Since a number of mouse models of cone dystrophy with cone opsin mislocalization exhibited M-opsin degradation and slower dorsal cone degeneration, e.g., cone cyclic nucleotide-gated channel A subunit (Cnga3) knockout (40) , GC1 (Gucy2e) knockout (LCA1) (41, 42) , Rd 3 (LCA12) (43), AIPL1 knockout (LCA4) (44) , and kinesin 3A (Kif3a) knockout in cones (45), M-opsin degradation associated proteasome stress may represent a general mechanism for dorsal cone degeneration in these models (Fig. 4) .
The most promising treatment for LRAT or RPE65 LCA is to use gene augmentation therapy with a normal copy of LRAT (or RPE65) to restore the visual cycle. In 2017, Luxturna was approved by Food and Drug Administration (FDA) for the treatment of RPE65-LCA (LCA2), making it the first directly administered gene therapy approved in the United States that targets a genetic disease caused by mutations in a specific gene. However, there were reports that photoreceptors continued to degenerate and vision benefit faded within 3 years despite initial vision gain after successful AAV-RPE65 therapy (11, 15, 16) . In addition, there was no improvement in foveal cone function despite AAV vectors having been delivered to the fovea in the majority of participants (16, 46) . These studies highlight the importance of understanding the mechanism of foveal cone degeneration and designing adjunct therapy to slow photoreceptor degeneration in LCA patients in future clinical gene therapy trials. The prominent role of cone opsins in cone degeneration suggests that, in addition to restoring the 11-cis-retinal supply, research needs to focus on the folding, trafficking, and degradation properties of cone opsins to design an effective prevention and treatment strategy. Our work demonstrated the importance of M-opsin degradation associated proteasome stress in L/M cone (the dominant cone type in the fovea). We propose to design drugs to help the folding and targeting of M/L-opsins and to enhance proteasome activity to slowdown cone degeneration as an adjunct treatment for gene therapy to achieve the best therapeutic efficacy for LCA ( Fig. 4) .
Experimental procedures
Mice. M-opsin -/mice were generated by CRISPR/Cas9 following a published protocol (47) . sgRNA (5'-ATTATCACATTGCTCCCAGG-3') was designed to target the second exon of mouse M-opsin gene Opn1mw. Cas9 plasmid and sgRNA were co-injected into C57Bl/6J mouse embryos at the University of Utah Transgenic/Gene Targeting Core Facility. Mouse tail samples from Opn1mw -/founder mice were prepared and used as PCR template with forward primer (5'-CATAGAGCAAGGAAAAGTGAGGTC-3') and reverse primer (5'-CCCAGAACGAAGTAGCCATAGAT-3'). The PCR product was gel purified and sequenced to select the founder mice. The pups of the Opn1mw -/founder mice were confirmed by DNA sequencing. Lrat -/-, Opn1sw -/-, and Lrat -/-Opn1sw -/mice were generated previously (4, 19, 33) . Opn1sw -/-Opn1mw -/mice were produced by crossing the Opn1sw -/and Opn1mw -/lines. Immunohistochemistry. The immunolabeling experiments were performed as previously described (8, 19) . Briefly, age-matched mouse eyes were immersion fixed for 2 h using freshly prepared 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, and cryoprotected. Eyes were sectioned at 12-14 µm thickness before being incubated for immunohistochemistry. Primary antibodies were applied to each group of two to four sections in a humidified chamber overnight at 4°C, and were visualized with Alexa 488-, Alexa 647-or Cy3-conjugated secondary antibodies. The sections were viewed using a Zeiss LSM 510 or LSM 800 confocal microscopes.
Lrat
Primary antibodies against S-opsin, M-opsin, cone arrestin, GRK1, and Gαt2 were described previously (8, 19) .
Western blotting. Retinas from 1-month WT and mutant mice were homogenized by a homogenizer. Protein concentrations were measured by BCA assay (Bio-Rad). 5µg retinal lysates were separated on 10% SDS-PAGE, transferred to a PVDF membrane, and probed with primary antibodies against M-opsin, S-opsin, and Gapdh as described previously (8, 19) . The signals were visualized by the ChemiDoc imaging system (Bio-Rad). 
Statistics

